AVE-3085 is primarily researched for its potential therapeutic applications in cardiovascular diseases. It is known to enhance endothelial nitric oxide synthase (eNOS) activity, which plays a crucial role in maintaining vascular health. By promoting the production of nitric oxide, it helps in vasodilation, improving blood flow, and reducing blood pressure. This makes it a promising candidate for treating conditions like hypertension, atherosclerosis, and other vascular disorders. Additionally, its ability to support endothelial function may contribute to the prevention of endothelial dysfunction, a common precursor to various cardiovascular complications. Research is ongoing to explore its efficacy and safety in clinical settings.